Osimertinib is a targeted therapy medication primarily used in the treatment of non-small cell lung cancer (NSCLC) harboring specific mutations in the epidermal growth factor receptor (EGFR). Its cost can vary based on factors such as brand, dosage, and regional pricing strategies. Below is a detailed overview of osimertinib, including its indications, pharmacology, dosage, side […]
Written by iebpharma
Recent advancements in lung cancer treatment have led to the development of several innovative therapies that offer hope for improved patient outcomes. These treatments encompass novel drug combinations, targeted therapies, and immunotherapies, each designed to address specific genetic mutations and tumor characteristics. 1. Amivantamab and Osicent 80 mg (Osimertinib) Combination: A groundbreaking combination of amivantamab, […]